Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03134222
Brief Title: Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)

First Submitted : April 25, 2017
First Submitted that Met QC Criteria : April 25, 2017
First Posted : April 28, 2017

Results First Submitted : March 9, 2020
Results First Submitted that Met QC Criteria : April 6, 2020
Results First Posted : April 8, 2020

Last Update Submitted that Met QC Criteria : June 1, 2020
Last Update Posted : June 9, 2020